Azucena Ogando-Esparis
Salamanca, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
VCAN Is Essential for ERK5-Driven Tumorigenesis in Soft Tissue Sarcoma.
Journal: International journal of biological sciences
Published: July 10, 2025
ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression.
Journal: International journal of molecular sciences
Published: February 02, 2024
Latent-Transforming Growth Factor β-Binding Protein 1/Transforming Growth Factor β1 Complex Drives Antitumoral Effects upon ERK5 Targeting in Melanoma.
Journal: The American journal of pathology
Published: September 15, 2023
The WNK1-ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib.
Journal: Clinical and translational medicine
Published: August 25, 2022
Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications.
Journal: Experimental & molecular medicine
Published: August 09, 2022
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology.
Journal: Cancers
Published: June 20, 2022
Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer.
Journal: NPJ precision oncology
Published: September 03, 2020
A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors.
Journal: Frontiers in immunology
Published: July 18, 2019
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 17, 2019
Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R-MEK5-Erk5 Pathway.
Journal: Cancer research
Published: September 03, 2018
Last Updated: 09/26/2026